Legacy Body Blog Skip list content Jul 21, 2026 Five emerging questions that belong in every IAM strategy discussion By the Imprivata editorial team Aug 3, 2026 Why “mostly CJIS compliant” is a risky place for public safety agencies to be By Nick Stohlman, VP of CJIS Program Strategy, Imprivata Jun 1, 2026 The hidden risk of lost mobile devices in healthcare: Why asset management is the fix By the Imprivata editorial team Industry All industries CJIS Commercial Financial services Gaming Healthcare Manufacturing Transportation and logistics Title Nov 13, 2014 Four Steps to Successfully Deploy Your Secure Clinical Communications Solution Sarah Ernst Nov 11, 2014 Two-Factor Authentication Considerations for e-Prescribing of Controlled Substances John Delcalzo Nov 7, 2014 VPNs at the root of home depot data breach Oct 29, 2014 How to Deliver a Signature Customer Experience…and Why it Matters Carina Edwards Oct 20, 2014 Why Electronic Prescribing of Controlled Substances Matters: the Pharmacy Perspective Oct 9, 2014 Health 2.0 Conference: Technology Investments for Tomorrow…and Today. Dr. Sean Kelly Oct 8, 2014 Survey: 50% of Physicians Never Check the PDMP when Prescribing Controlled Substances Dr. Sean Kelly Oct 7, 2014 Feeling the Pain of Meaningful Use Stage 2? Try Vicodin David Ting Sep 29, 2014 Three Key Considerations for Successfully Enabling Electronic Prescribing of Controlled Substances David Ting Pagination First page Previous page … Page 100 Page 101 Page 102 Page 103 … Next page Last page
